MERSEN (MRN.PA) Fundamental Analysis & Valuation

EPA:MRN • FR0000039620

Current stock price

22 EUR
+0.15 (+0.69%)
Last:

This MRN.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. MRN.PA Profitability Analysis

1.1 Basic Checks

  • MRN had positive earnings in the past year.
  • MRN had a positive operating cash flow in the past year.
  • Of the past 5 years MRN 4 years were profitable.
  • Each year in the past 5 years MRN had a positive operating cash flow.
MRN.PA Yearly Net Income VS EBIT VS OCF VS FCFMRN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.71%, MRN is in line with its industry, outperforming 53.62% of the companies in the same industry.
  • MRN's Return On Equity of 6.25% is in line compared to the rest of the industry. MRN outperforms 52.17% of its industry peers.
  • With a Return On Invested Capital value of 6.57%, MRN perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for MRN is in line with the industry average of 9.51%.
Industry RankSector Rank
ROA 2.71%
ROE 6.25%
ROIC 6.57%
ROA(3y)4.43%
ROA(5y)3.3%
ROE(3y)9.18%
ROE(5y)6.84%
ROIC(3y)7.82%
ROIC(5y)7.1%
MRN.PA Yearly ROA, ROE, ROICMRN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8 10

1.3 Margins

  • MRN has a Profit Margin (4.02%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of MRN has declined.
  • With a decent Operating Margin value of 9.66%, MRN is doing good in the industry, outperforming 72.46% of the companies in the same industry.
  • MRN's Operating Margin has been stable in the last couple of years.
  • Looking at the Gross Margin, with a value of 29.63%, MRN is doing worse than 63.77% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MRN has remained more or less at the same level.
Industry RankSector Rank
OM 9.66%
PM (TTM) 4.02%
GM 29.63%
OM growth 3Y1.63%
OM growth 5Y-0.4%
PM growth 3Y-6.98%
PM growth 5Y-4.68%
GM growth 3Y-0.41%
GM growth 5Y-0.36%
MRN.PA Yearly Profit, Operating, Gross MarginsMRN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. MRN.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MRN is creating some value.
  • The number of shares outstanding for MRN has been increased compared to 1 year ago.
  • Compared to 5 years ago, MRN has more shares outstanding
  • The debt/assets ratio for MRN is higher compared to a year ago.
MRN.PA Yearly Shares OutstandingMRN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
MRN.PA Yearly Total Debt VS Total AssetsMRN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 1.93 indicates that MRN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • MRN has a Altman-Z score (1.93) which is in line with its industry peers.
  • MRN has a debt to FCF ratio of 33.11. This is a negative value and a sign of low solvency as MRN would need 33.11 years to pay back of all of its debts.
  • MRN has a Debt to FCF ratio of 33.11. This is comparable to the rest of the industry: MRN outperforms 46.38% of its industry peers.
  • MRN has a Debt/Equity ratio of 0.57. This is a neutral value indicating MRN is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.57, MRN is in line with its industry, outperforming 49.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 33.11
Altman-Z 1.93
ROIC/WACC0.86
WACC7.61%
MRN.PA Yearly LT Debt VS Equity VS FCFMRN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • MRN has a Current Ratio of 1.39. This is a normal value and indicates that MRN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.39, MRN perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
  • A Quick Ratio of 0.81 indicates that MRN may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.81, MRN perfoms like the industry average, outperforming 42.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 0.81
MRN.PA Yearly Current Assets VS Current LiabilitesMRN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. MRN.PA Growth Analysis

3.1 Past

  • The earnings per share for MRN have decreased strongly by -35.55% in the last year.
  • The Earnings Per Share has been decreasing by -1.64% on average over the past years.
  • MRN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.23%.
  • The Revenue has been growing slightly by 5.53% on average over the past years.
EPS 1Y (TTM)-35.55%
EPS 3Y-1.43%
EPS 5Y-1.64%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)0.23%
Revenue growth 3Y10.46%
Revenue growth 5Y5.53%
Sales Q2Q%-2.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 22.45% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, MRN will show a quite strong growth in Revenue. The Revenue will grow by 10.90% on average per year.
EPS Next Y-13.72%
EPS Next 2Y0.32%
EPS Next 3Y6.1%
EPS Next 5Y22.45%
Revenue Next Year-4.3%
Revenue Next 2Y-0.48%
Revenue Next 3Y1.77%
Revenue Next 5Y10.9%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MRN.PA Yearly Revenue VS EstimatesMRN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
MRN.PA Yearly EPS VS EstimatesMRN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

6

4. MRN.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • MRN is valuated reasonably with a Price/Earnings ratio of 11.06.
  • Based on the Price/Earnings ratio, MRN is valued cheaply inside the industry as 94.20% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 25.54. MRN is valued rather cheaply when compared to this.
  • MRN is valuated cheaply with a Price/Forward Earnings ratio of 7.65.
  • 91.30% of the companies in the same industry are more expensive than MRN, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, MRN is valued rather cheaply.
Industry RankSector Rank
PE 11.06
Fwd PE 7.65
MRN.PA Price Earnings VS Forward Price EarningsMRN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 92.75% of the companies in the same industry are more expensive than MRN, based on the Enterprise Value to EBITDA ratio.
  • 62.32% of the companies in the same industry are more expensive than MRN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 29.2
EV/EBITDA 4.83
MRN.PA Per share dataMRN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.32%
EPS Next 3Y6.1%

6

5. MRN.PA Dividend Analysis

5.1 Amount

  • MRN has a Yearly Dividend Yield of 3.96%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.96, MRN pays a better dividend. On top of this MRN pays more dividend than 97.10% of the companies listed in the same industry.
  • MRN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.96%

5.2 History

  • The dividend of MRN has a limited annual growth rate of 4.49%.
Dividend Growth(5Y)4.49%
Div Incr Years0
Div Non Decr Years3
MRN.PA Yearly Dividends per shareMRN.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 62.63% of the earnings are spent on dividend by MRN. This is not a sustainable payout ratio.
  • MRN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.63%
EPS Next 2Y0.32%
EPS Next 3Y6.1%
MRN.PA Yearly Income VS Free CF VS DividendMRN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M
MRN.PA Dividend Payout.MRN.PA Dividend Payout, showing the Payout Ratio.MRN.PA Dividend Payout.PayoutRetained Earnings

MRN.PA Fundamentals: All Metrics, Ratios and Statistics

MERSEN

EPA:MRN (3/24/2026, 5:29:56 PM)

22

+0.15 (+0.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)03-18
Earnings (Next)04-28
Inst Owners57.48%
Inst Owner ChangeN/A
Ins Owners0.29%
Ins Owner ChangeN/A
Market Cap537.24M
Revenue(TTM)1.23B
Net Income(TTM)49.50M
Analysts80
Price Target29.85 (35.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.96%
Yearly Dividend1.27
Dividend Growth(5Y)4.49%
DP62.63%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.09%
PT rev (3m)0.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.16%
EPS NY rev (3m)-1.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)-0.58%
Valuation
Industry RankSector Rank
PE 11.06
Fwd PE 7.65
P/S 0.44
P/FCF 29.2
P/OCF 2.47
P/B 0.68
P/tB 1.21
EV/EBITDA 4.83
EPS(TTM)1.99
EY9.05%
EPS(NY)2.87
Fwd EY13.07%
FCF(TTM)0.75
FCFY3.42%
OCF(TTM)8.91
OCFY40.52%
SpS50.37
BVpS32.44
TBVpS18.12
PEG (NY)N/A
PEG (5Y)N/A
Graham Number38.11
Profitability
Industry RankSector Rank
ROA 2.71%
ROE 6.25%
ROCE 8.79%
ROIC 6.57%
ROICexc 7.51%
ROICexgc 10.64%
OM 9.66%
PM (TTM) 4.02%
GM 29.63%
FCFM 1.5%
ROA(3y)4.43%
ROA(5y)3.3%
ROE(3y)9.18%
ROE(5y)6.84%
ROIC(3y)7.82%
ROIC(5y)7.1%
ROICexc(3y)8.35%
ROICexc(5y)7.71%
ROICexgc(3y)11.56%
ROICexgc(5y)11.01%
ROCE(3y)10.7%
ROCE(5y)9.74%
ROICexgc growth 3Y-0.83%
ROICexgc growth 5Y-3.01%
ROICexc growth 3Y1.22%
ROICexc growth 5Y-1.49%
OM growth 3Y1.63%
OM growth 5Y-0.4%
PM growth 3Y-6.98%
PM growth 5Y-4.68%
GM growth 3Y-0.41%
GM growth 5Y-0.36%
F-Score4
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 33.11
Debt/EBITDA 2.28
Cap/Depr 252.28%
Cap/Sales 16.2%
Interest Coverage 5.58
Cash Conversion 110.06%
Profit Quality 37.17%
Current Ratio 1.39
Quick Ratio 0.81
Altman-Z 1.93
F-Score4
WACC7.61%
ROIC/WACC0.86
Cap/Depr(3y)237.61%
Cap/Depr(5y)200.5%
Cap/Sales(3y)14.05%
Cap/Sales(5y)11.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.55%
EPS 3Y-1.43%
EPS 5Y-1.64%
EPS Q2Q%-24.55%
EPS Next Y-13.72%
EPS Next 2Y0.32%
EPS Next 3Y6.1%
EPS Next 5Y22.45%
Revenue 1Y (TTM)0.23%
Revenue growth 3Y10.46%
Revenue growth 5Y5.53%
Sales Q2Q%-2.18%
Revenue Next Year-4.3%
Revenue Next 2Y-0.48%
Revenue Next 3Y1.77%
Revenue Next 5Y10.9%
EBIT growth 1Y-14.22%
EBIT growth 3Y12.26%
EBIT growth 5Y5.11%
EBIT Next Year68.99%
EBIT Next 3Y26.31%
EBIT Next 5Y29.42%
FCF growth 1Y187.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.17%
OCF growth 3Y18.43%
OCF growth 5Y9.52%

MERSEN / MRN.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MERSEN?

ChartMill assigns a fundamental rating of 4 / 10 to MRN.PA.


What is the valuation status for MRN stock?

ChartMill assigns a valuation rating of 6 / 10 to MERSEN (MRN.PA). This can be considered as Fairly Valued.


What is the profitability of MRN stock?

MERSEN (MRN.PA) has a profitability rating of 4 / 10.


How financially healthy is MERSEN?

The financial health rating of MERSEN (MRN.PA) is 3 / 10.


What is the earnings growth outlook for MERSEN?

The Earnings per Share (EPS) of MERSEN (MRN.PA) is expected to decline by -13.72% in the next year.